Corient Private Wealth’s Dynavax Technologies DVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding DVAX
DTC
CC
KCM
Corient Private Wealth's DVAX Position: Q2 2025 in Review
Corient Private Wealth sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 19,329 shares — an estimated $251K sold.
Corient Private Wealth first reported a position in DVAX in Q2 2024 and held it in 4 quarters. The position peaked at $251K in Q1 2025. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.
- Corient Private Wealth reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
- Corient Private Wealth sold 19,329 Dynavax Technologies shares in Q2 2025, an estimated $251K.
- Corient Private Wealth first reported a position in Dynavax Technologies in Q2 2024 and held it in 4 quarters.
- Corient Private Wealth's Dynavax Technologies position peaked at $251K in Q1 2025.
- 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.
Based on Corient Private Wealth's 13F filing for Q2 2025, filed 15 Aug 2025.